Amgen’s Lowe on QbD, Process Scale and Standardization for Biopharma

July 1, 2009
1530 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
Scale is a function of patient requirements and manufacturing productivity, says Amgen scientific executive director Duncan Lowe. Where QbD’s... » More